BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24847468)

  • 21. Thyroid-stimulating hormone-secreting pituitary adenoma presenting with recurrent hyperthyroidism in post-treated Graves' disease: a case report.
    Ogawa Y; Tominaga T
    J Med Case Rep; 2013 Jan; 7():27. PubMed ID: 23336522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary hyperplasia mimicking thyrotropin-producing pituitary adenoma in the patient with resistance to thyroid hormone: a case report.
    Suntornlohanakul O; Sriphrapradang C
    Int J Neurosci; 2022 Feb; 132(2):207-211. PubMed ID: 32727243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graves' disease with only unilateral involvement; a case report.
    Bu Bshait MS
    Int J Surg Case Rep; 2024 Jan; 114():109138. PubMed ID: 38086135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness.
    Macchia E; Concetti R; Borgoni F; Cetani F; Fenzi GF; Pinchera A
    Autoimmunity; 1989; 3(2):103-12. PubMed ID: 2577491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plurihormonal (TSH-GH-prolactin Secreting) PIT-1-Positive pituitary Macroadenoma/Pituitary Neuroendocrine Tumor (PitNET) Associated with Graves' Disease: A Case Report.
    Morgante C; Guaraldi F; Asioli S; Mazzatenta D; Papi G; Pontecorvi A
    Endocr Metab Immune Disord Drug Targets; 2023; 23(12):1557-1561. PubMed ID: 37357515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ectopic TSH-secreting pituitary adenoma of the vomerosphenoidal junction.
    Pasquini E; Faustini-Fustini M; Sciarretta V; Saggese D; Roncaroli F; Serra D; Frank G
    Eur J Endocrinol; 2003 Feb; 148(2):253-7. PubMed ID: 12590646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A thyrotropin-secreting macroadenoma with positive growth hormone and prolactin immunostaining: A case report and literature review.
    Kuzu F; Bayraktaroğlu T; Zor F; G N BD; Salihoğlu YS; Kalaycı M
    Niger J Clin Pract; 2015; 18(5):693-7. PubMed ID: 26096253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
    Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
    Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D
    J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
    Maugendre D; Massart C
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Rare Case of Thyrotropin-Secreting Pituitary Adenoma Coexisting with Papillary Thyroid Carcinoma Presenting with Visual Disturbance without Hyperthyroidism.
    Inoue H; Shinojima N; Ueda R; Yamamoto K; Ishii N; Igata M; Kawashima J; Araki E; Iwase H; Mikami Y; Yano S; Mukasa A
    World Neurosurg; 2018 Nov; 119():394-399. PubMed ID: 30096503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid storm with encephalopathic symptoms due to Graves' disease and inappropriate secretion of thyrotropin.
    Modignani RL; Venegoni M; Beretta F; Fassina S
    Ann Ital Med Int; 1992; 7(4):250-4. PubMed ID: 1298337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TSH-induced hyperthyroidism caused by a pituitary tumor.
    Beck-Peccoz P; Persani L
    Nat Clin Pract Endocrinol Metab; 2006 Sep; 2(9):524-8; quiz following p528. PubMed ID: 16957766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid color flow Doppler sonography: an adjunctive tool for differentiating patients with inappropriate thyrotropin (TSH) secretion due to TSH-secreting pituitary adenoma or resistance to thyroid hormone.
    Bogazzi F; Manetti L; Tomisti L; Rossi G; Cosci C; Sardella C; Bartalena L; Gasperi M; Macchia E; Vitti P; Martino E
    Thyroid; 2006 Oct; 16(10):989-95. PubMed ID: 17042684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic recurrent stress due to panic disorder does not precipitate Graves' disease.
    Chiovato L; Marinò M; Perugi G; Fiore E; Montanelli L; Lapi P; Cavaliere R; Ciampi M; Patronelli A; Placidi G; Placidi GF; Cassano GB; Pinchera A
    J Endocrinol Invest; 1998 Dec; 21(11):758-64. PubMed ID: 9972676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous Coexistence of Thyrotropin-Prolactin-Secreting Adenoma and Papillary Thyroid Carcinoma.
    Safi S; Benabdelfedil Y; Derrou S; El Guendouz F
    Case Rep Endocrinol; 2021; 2021():6564765. PubMed ID: 34888106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged suppressed thyroid-stimulating hormone levels in hyperthyroidism in a neonate born to a mother with Graves' disease.
    Hojo M; Momotani N; Ikeda N; Ueda A; Uno K; Ishikita T; Ishiguro A; Shimbo T
    Acta Paediatr Jpn; 1998 Oct; 40(5):483-5. PubMed ID: 9821712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics of patients with thyrotropin-secreting pituitary adenoma.
    Wu YY; Chang HY; Lin JD; Chen KW; Huang YY; Jung SM
    J Formos Med Assoc; 2003 Mar; 102(3):164-71. PubMed ID: 12783133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.